Drug Discovery News and Research

RSS

The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.

New approach to elevate health and well-being by optimizing late-life brain capital

Within many societies and cultures around the world, older adults are too often undervalued and underappreciated, according to a new article in the journal Innovation in Aging.

18 May 2022

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

18 May 2022

A*STAR, NHCS, NUS, and Novo Nordisk partner to study the mechanisms underlying heart failure

The Agency for Science, Technology and Research's Genome Institute of Singapore and Bioinformatics Institute, as well as the National Heart Centre Singapore, National University of Singapore, and pharmaceutical company Novo Nordisk have signed an agreement to study the mechanisms underlying cardiovascular disease progression - especially the condition called heart failure with preserved ejection fraction (HFpEF).

13 May 2022

bit.bio launches Huntington’s disease human cell model

First neurodegenerative disease model launched from bit.bio's new ioDisease Model portfolio.

From bit.bio 10 May 2022

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

...

From Dotmatics 5 May 2022

New model can predict drug-drug interactions based on drug-induced gene expression signatures

Prescriptions for multiple drugs, or polypharmacy, is often recommended for the treatment of complex diseases.

4 May 2022

Discovery could lead to new treatments to minimize cravings in people with addictions

For some people with alcohol use disorder, it might be the sight of a familiar bar or a favorite bottle; for others, it might be the feeling of leaving the office after a stressful day at work or stepping into a crowded party. Most people who struggle with drug or alcohol addiction have particular cues that set off their cravings.

4 May 2022

MIT researchers develop a smarter method to discover new drugs

Pharmaceutical companies are using artificial intelligence to streamline the process of discovering new medicines.

27 Apr 2022

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Cancer Research UK, today unveiled Cancer Research Horizons, its new and ambitious approach to driving innovation in the development of new treatments for patients.

From Cancer Research UK 27 Apr 2022

UNIGE scientists develop a novel tool to visualize palmitoylation process in living cells

Peripheral membrane proteins have the particularity of temporarily binding to cell membranes, a necessary step for them to be able to fulfil their biological function.

26 Apr 2022

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

Dotmatics was today announced as the formal name and brand for the combined entities of Insightful Science and Dotmatics.

From Dotmatics 26 Apr 2022

Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume

Dotphoton, an industry-leading raw image compression company and Hamamatsu Photonics, a world leader in optical systems and photonics manufacturing, are pleased to announce their new partnership.

From Hamamatsu Photonics Europe 26 Apr 2022

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

First product within new ‘in-a-box’ range, which harnesses next-generation, human-relevant Liver-on-a-Chip technology to improve the accuracy and efficiency of NASH drug discovery.

From CN Bio 26 Apr 2022

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

As part of World Malaria Day 2022, we interview Karine Le Roch PH.D., about her latest research into how novel antimalarial therapeutic strategies could be on the horizon, after identifying two proteins that are critical to the survival of the malaria parasite, Plasmodium falciparum.

25 Apr 2022

Reaction Biology's Novel Approach to Oncology Drug Discovery at AACR Showcase

Reaction Biology, an industry-leading provider of drug discovery services, today announced that twelve abstracts highlighting data from the Company's oncology drug discovery services platform will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2022, held April 8-13, 2022, in New Orleans, Louisiana.

From Reaction Biology Corporation 13 Apr 2022

Drug Discovery News and Research

Further Reading

New approach to elevate health and well-being by optimizing late-life brain capital

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

A*STAR, NHCS, NUS, and Novo Nordisk partner to study the mechanisms underlying heart failure

bit.bio launches Huntington’s disease human cell model

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

New model can predict drug-drug interactions based on drug-induced gene expression signatures

Discovery could lead to new treatments to minimize cravings in people with addictions

MIT researchers develop a smarter method to discover new drugs

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

UNIGE scientists develop a novel tool to visualize palmitoylation process in living cells

Dotmatics, previously Insightful Science, set to transform the future of scientific software and data management

Dotphoton and Hamamatsu Photonics are partnering to provide the ultimate raw image compression and address the ever-growing biomedical image data volume

CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

Reaction Biology's Novel Approach to Oncology Drug Discovery at AACR Showcase

Epigenetics likely to be the reason why lung cancer patients develop treatment resistance

Nemours Children’s Health scientists receive two NIH grants to advance pediatric cancer research

Venomtech announces new drug development collaboration with Charles River

Nanocell COVID-19 vaccine elicits potent neutralizing response

A novel PLpro inhibitor as a broad-spectrum anti-coronavirus agent

Event guide: World ADC Asia eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo